US 10562975
CD6 antibody for treatment of T-cell mediated diseases or disorders
granted A61KA61K2039/505A61P
Quick answer
US patent 10562975 (CD6 antibody for treatment of T-cell mediated diseases or disorders) held by THE REGENTS OF THE UNIVERSITY OF MICHIGAN expires Mon Feb 13 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- THE REGENTS OF THE UNIVERSITY OF MICHIGAN
- Grant date
- Tue Feb 18 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 13 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61K, A61K2039/505, A61P, A61P37/06